INTENSITY THERAPEUTICS, INC. - 10-Q Filing

Intensity Therapeutics reports third quarter 2026 financial results with 3.3 million shares outstanding as of November 4, 2026.

SEC EDGAR ·

Tickers: $INTS

Read the full article at SEC EDGAR

More Regulatory news